Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Quantum Biopharma ( (TSE:QNTM) ) is now available.
Quantum BioPharma has successfully closed a non-brokered private placement, issuing 30 Class A Multiple Voting Shares at $25 each, generating $750 in gross proceeds. The funds will be used for general working capital, with significant insider participation from Xorax Family Trust and Fortius Research and Trading Corp., highlighting a related-party transaction under MI 61-101. This transaction increases Xorax’s voting rights and ownership, impacting the company’s governance structure.
More about Quantum Biopharma
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative assets and biotech solutions for treating neurodegenerative, metabolic, and alcohol misuse disorders. The company has a range of drug candidates at various stages of development.
Average Trading Volume: 4,906
Technical Sentiment Signal: Sell
Current Market Cap: C$54.7M
See more data about QNTM stock on TipRanks’ Stock Analysis page.